| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Integration Officer | Chief Regulatory Officer
1 company
Lloyd-Smith Malcolm is a Chief Integration Officer at NBIX. Recent filings cover 0 purchases and 45 sales. Those positions are worth an estimated $4.4M at current prices.
Our model assigns Lloyd-Smith Malcolm a below-average insider score of 49/100, based on 8 past trades. Over a 12-month horizon, 12.5% of those trades were profitable, with an average 12-month return of -22.8%.
Lloyd-Smith Malcolm's largest disclosed position is in NBIX as Chief Integration Officer, worth about $4.4M. The recent filings there lean toward selling, a net 187,034 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | NBIX Neurocrine Biosciences Inc | Chief Integration Officer | Sell | 15,318 | $102.64 | $1,572,196.57 | -26.6% | -6.9% | +28.6% | |
| Jan 31, 2023 | NBIX Neurocrine Biosciences Inc | Chief Integration Officer | Sell | 1,666 | $110.02 | $183,290.49 | -5.5% | -6.2% | +26.0% | |
| Aug 12, 2022 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 21,533 | $105.95 | $2,281,330.91 | -53.3% | +16.7% | -0.4% | |
| Feb 8, 2022 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 3,382 | $80.48 | $272,167.90 | -15.3% | -5.2% | +30.7% | |
| Jul 27, 2021 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 16,709 | $93.80 | $1,567,335.95 | -51.4% | +9.0% | +1.5% | |
| Feb 10, 2021 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 1,700 | $119.96 | $203,925.55 | -5.0% | - | - | |
| Feb 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 4,126 | $116.26 | $479,668.44 | -11.3% | - | - | |
| Jan 26, 2021 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 18,670 | $119.97 | $2,239,777.48 | -39.2% | - | - | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 2,257 | $90.73 | $204,775.80 | -7.2% | - | - | |
| Aug 5, 2020 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 2,257 | $118.86 | $268,277.40 | -7.7% | - | - |